BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23224022)

  • 1. Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents.
    Davis NF; Kheradmand F; Creagh T
    Int Urogynecol J; 2013 Jun; 24(6):913-9. PubMed ID: 23224022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis.
    Leone Roberti Maggiore U; Bogani G; Meschia M; Sorice P; Braga A; Salvatore S; Ghezzi F; Serati M
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():48-54. PubMed ID: 25855326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond collagen: injectable therapies for the treatment of female stress urinary incontinence in the new millennium.
    Kershen RT; Dmochowski RR; Appell RA
    Urol Clin North Am; 2002 Aug; 29(3):559-74. PubMed ID: 12476520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urethral injection therapy for urinary incontinence in women.
    Kirchin V; Page T; Keegan PE; Atiemo K; Cody JD; McClinton S
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003881. PubMed ID: 22336797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bulking agents: an analysis of 500 cases and review of the literature.
    Mohr S; Siegenthaler M; Mueller MD; Kuhn A
    Int Urogynecol J; 2013 Feb; 24(2):241-7. PubMed ID: 22707004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urethral injections for female stress incontinence.
    Appell RA; Dmochowski RR; Herschorn S
    BJU Int; 2006 Sep; 98 Suppl 1():27-30; discussion 31. PubMed ID: 16911598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection therapy for stress urinary incontinence in adult women.
    ter Meulen H; van Kerrebroeck E
    Expert Rev Med Devices; 2004 Nov; 1(2):205-13. PubMed ID: 16293041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections.
    Schulz JA; Nager CW; Stanton SL; Baessler K
    Int Urogynecol J Pelvic Floor Dysfunct; 2004; 15(4):261-5. PubMed ID: 15517671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation.
    Futyma K; Miotła P; Gałczyński K; Baranowski W; Doniec J; Wodzisławska A; Jóźwik M; Oniszczuk M; Rechberger T
    Biomed Res Int; 2015; 2015():851823. PubMed ID: 26106616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of urethral bulking therapy for female stress urinary incontinence.
    Kocjancic E; Mourad S; Acar Ö
    Neurourol Urodyn; 2019 Aug; 38 Suppl 4():S12-S20. PubMed ID: 31066956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive porous beads as an injectable urethral bulking agent: in vivo animal study for the treatment of urinary incontinence.
    Kim IG; Oh SH; Lee JY; Lee JY; Lee JH
    Tissue Eng Part A; 2011 Jun; 17(11-12):1527-35. PubMed ID: 21275847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of sling for persistent stress urinary incontinence after bulking injection.
    Koski ME; Enemchukwu EA; Padmanabhan P; Kaufman MR; Scarpero HM; Dmochowski RR
    Urology; 2011 May; 77(5):1076-80. PubMed ID: 21216448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Urethral Bulking Agents Salvage Failed Slings?
    Dray EV; Hall M; Covalschi D; Cameron AP
    Urology; 2019 Feb; 124():78-82. PubMed ID: 30412703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the available urethral bulking agents.
    Lightner DJ
    Curr Opin Urol; 2002 Jul; 12(4):333-8. PubMed ID: 12072655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable agents: present and future.
    Lightner DJ; Itano NB; Sweat SD; Chrouser KL; Fick F
    Curr Urol Rep; 2002 Oct; 3(5):408-13. PubMed ID: 12354352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of injectable agents for treatment of stress urinary incontinence in women: evolving techniques.
    Dmochowski RR; Appell RA
    Tech Urol; 2001 Jun; 7(2):110-7. PubMed ID: 11383988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of urethral bulking injections in post-prostatectomy stress urinary incontinence: A narrative review of the literature.
    Nguyen L; Leung LY; Walker R; Nitkunan T; Sharma D; Seth J
    Neurourol Urodyn; 2019 Nov; 38(8):2060-2069. PubMed ID: 31432568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic production of bioactive fibrin micro-beads embedded in crosslinked collagen used as an injectable bulking agent for urinary incontinence treatment.
    Vardar E; Larsson HM; Allazetta S; Engelhardt EM; Pinnagoda K; Vythilingam G; Hubbell JA; Lutolf MP; Frey P
    Acta Biomater; 2018 Feb; 67():156-166. PubMed ID: 29197579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review.
    Siddiqui ZA; Abboudi H; Crawford R; Shah S
    Int Urogynecol J; 2017 Sep; 28(9):1275-1284. PubMed ID: 28220200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel injectable urethral bulking agents for the treatment of urinary incontinence.
    Jordan O; Doelker E; Defabiani N; Caviezel A; Iselin C
    J Mater Sci Mater Med; 2004 Apr; 15(4):519-22. PubMed ID: 15332628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.